The efficacy and safety of leflunomide i
✍
J. R. Kalden; M. Schattenkirchner; H. Sörensen; P. Emery; C. Deighton; B. Rozman
📂
Article
📅
2003
🏛
John Wiley and Sons
🌐
English
⚖ 123 KB
👁 2 views
## Abstract ## Objective To investigate the efficacy and safety of leflunomide beyond 2 years in a multinational, open‐label extension of 2 phase III double‐blind studies. ## Methods Patients with rheumatoid arthritis (RA) who received leflunomide (100 mg/day for 3 days, 10 mg/day or 20 mg/day t